The role of the carbohydrate response element-binding protein in male fructose-fed rats

Endocrinology

Volumn 154, Issue 1, 2013, Pages 36-44

  Erion, Derek M ^a   Popov, Violetta ^a   Hsiao, Jennifer J ^a   Vatner, Daniel ^a   Mitchell, Kisha ^a   Yonemitsu, Shin ^a   Nagai, Yoshio ^a   Kahn, Mario ^a   Gillum, Matthew P ^c   Dong, Jianying ^a   Murray, Susan F ^b   Manchem, Vara Prasad ^b   Bhanot, Sanjay ^b   Cline, Gary W ^a   Shulman, Gerald I ^a   Samuel, Varman T ^a,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ISIS PHARMACEUTICALS   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COA CARBOXYLASE 2; ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE 1; ALANINE AMINOTRANSFERASE; ANTISENSE OLIGONUCLEOTIDE; ASPARTATE AMINOTRANSFERASE; CARBOHYDRATE BINDING PROTEIN; FAS ANTIGEN; FRUCTOKINASE; FRUCTOSE; FRUCTOSE ALDOLASE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; GLUCOSE TRANSPORT; HEREDITARY FRUCTOSE INTOLERANCE; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIPID DIET; LIPID LIVER LEVEL; LIPOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RAT; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ACETYL-COA CARBOXYLASE; ANIMALS; ANTIGENS, CD95; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARRIER PROTEINS; FRUCTOSE; LIVER; MALE; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, SPRAGUE-DAWLEY; STEAROYL-COA DESATURASE; TRIGLYCERIDES;

EID: 84871709488     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1725     Document Type: Article

References (39)

1. Samuel VT 2011 Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol Metab 22:60-65
2. Bray GA, Nielsen SJ, Popkin BM 2004 Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79:537-543
3. Nagai Y, Nishio Y, Nakamura T, Maegawa H, Kikkawa R, Kashiwagi A 2002 Amelioration of high fructose-induced metabolic derangements by activation of PPARα. Am J Physiol Endocrinol Metab 282:E1180-E1190 (Pubitemid 34654734)
4. Hudgins LC, Parker TS, Levine DM, Hellerstein MK 2011 A dual sugar challenge test for lipogenic sensitivity to dietary fructose. J Clin Endocrinol Metab 96:861-868
5. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ 2009 Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119:1322-1334
6. Nagai Y, Yonemitsu S, Erion DM, Iwasaki T, Stark R, Weismann D, Dong J, Zhang D, Jurczak MJ, Löffler MG, Cresswell J, Yu XX, Murray SF, Bhanot S, Monia BP, Bogan JS, Samuel V, Shulman GI 2009 The role of peroxisome proliferator-activated receptor γ co-activator-1β in the pathogenesis of fructose-induced insulin resistance. Cell metabolism 9:252-264
7. Erion DM, Shulman GI 2010 Diacylglycerol-mediated insulin resistance. Nat Med 16:400-402
8. Samuel VT, Liu ZX, Wang A, Beddow SA, Geisler JG, Kahn M, Zhang XM, Monia BP, Bhanot S, Shulman GI 2007 Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest 117:739-745 (Pubitemid 46348532)
9. Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X, Still CD, Gerhard GS, Han X, Dziura J, Petersen KF, Samuel VT, Shulman GI 2011 Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA 108:16381-16385
10. Lee AH, Scapa EF, Cohen DE, Glimcher LH 2008 Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 320:1492-1496 (Pubitemid 351929428)
11. Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS 2002 Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem 277:9520-9528 (Pubitemid 34953041)
12. Uyeda K, Repa JJ 2006 Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab 4:107-110 (Pubitemid 44138720)
13. Iizuka K, Horikawa Y 2008 ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Endocr J 55:617-624
14. Kabashima T, Kawaguchi T, Wadzinski BE, Uyeda K 2003 Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci USA 100:5107-5112 (Pubitemid 36542666)
15. Koo HY, Miyashita M, Cho BH, Nakamura MT 2009 Replacing dietary glucose with fructose increases ChREBP activity and SREBP-1 protein in rat liver nucleus. Biochem Biophys Res Commun 390:285-289
16. Dentin R, Tomas-Cobos L, Foufelle F, Leopold J, Girard J, Postic C, Ferré P 2012 Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. J Hepatol 56:199-209
17. Herman MA, Peroni OD, Villoria J, Schön MR, Abumrad NA, Blüher M, Klein S, Kahn BB 2012 A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature 484:333-338
18. Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C 2006 Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 55:2159-2170 (Pubitemid 44743612)
19. Watts LM, Manchem VP, Leedom TA, Rivard AL, McKay RA, Bao D, Neroladakis T, Monia BP, Bodenmiller DM, Cao JX, Zhang HY, Cox AL, Jacobs SJ, Michael MD, Sloop KW, Bhanot S 2005 Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism. Diabetes 54:1846-1853 (Pubitemid 40770776)
20. Erion DM, Yonemitsu S, Nie Y, Nagai Y, Gillum MP, Hsiao JJ, Iwasaki T, Stark R, Weismann D, Yu XX, Murray SF, Bhanot S, Monia BP, Horvath TL, Gao Q, Samuel VT, Shulman GI 2009 SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats. Proc Natl Acad Sci USA 106:11288-11293
21. Erion DM, Ignatova ID, Yonemitsu S, Nagai Y, Chatterjee P, Weismann D, Hsiao JJ, Zhang D, Iwasaki T, Stark R, Flannery C, Kahn M, Carmean CM, Yu XX, Murray SF, Bhanot S, Monia BP, Cline GW, Samuel VT, Shulman GI 2009 Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein. Cell Metab 10:499-506
22. Bligh EG, Dyer WJ 1959 A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917
23. Neschen S, Moore I, Regittnig W, Yu CL, Wang Y, Pypaert M, Petersen KF, Shulman GI 2002 Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content. Am J Physiol Endocrinol Metab 282:E395-E401 (Pubitemid 34654810)
24. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ 2005 Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313-1321 (Pubitemid 40770284)
25. Previs SF, Hazey JW, Diraison F, Beylot M, David F, Brunengraber H 1996 Assay of the deuterium enrichment of water via acetylene. J Mass Spectrom 31:639-642 (Pubitemid 26186895)
26. Diraison F, Pachiaudi C, Beylot M 1997 Measuring lipogenesis and cholesterol synthesis in humans with deuterated water: use of simple gas chromatographic/mass spectrometric techniques. J Mass Spectrom 32:81-86 (Pubitemid 27046476)
27. Diraison F, Pachiaudi C, Beylot M 1996 In vivo measurement of plasma cholesterol and fatty acid synthesis with deuterated water: determination of the average number of deuterium atoms incorporated. Metabolism 45:817-821 (Pubitemid 26249745)
28. Li MV, Chen W, Harmancey RN, Nuotio-Antar AM, Imamura M, Saha P, Taegtmeyer H, Chan L 2011 Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). Biochem Biophys Res Commun 395:395-400
29. Van Schaftingen E, Vandercammen A 1989 Stimulation of glucose phosphorylation by fructose in isolated rat hepatocytes. Eur J Biochem 179:173-177 (Pubitemid 19097673)
30. Hussain MM, Rava P, Pan X, Dai K, Dougan SK, Iqbal J, Lazare F, Khatun I 2008 Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism. Curr Opin Lipidol 19:277-284 (Pubitemid 351653566)
31. Ma L, Robinson LN, Towle HC 2006 ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver. J Biol Chem 281:28721-28730 (Pubitemid 44507014)
32. Raabe M, Véniant MM, Sullivan MA, Zlot CH, Björkegren J, Nielsen LB, Wong JS, Hamilton RL, Young SG 1999 Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest 103:1287-1298 (Pubitemid 29218299)
33. Chandler CE, Wilder DE, Pettini JL, Savoy YE, Petras SF, Chang G, Vincent J, Harwood Jr HJ 2003 CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans. J Lipid Res 44:1887-1901 (Pubitemid 37356661)
34. Lettéron P, Sutton A, Mansouri A, Fromenty B, Pessayre D 2003 Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology 38:133-140 (Pubitemid 36775804)
35. Iizuka K, Bruick RK, Liang G, Horton JD, Uyeda K 2004 Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci USA 101:7281-7286 (Pubitemid 38638024)
36. Iizuka K, Miller B, Uyeda K 2006 Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice. Am J Physiol Endocrinol Metab 291:E358-E364 (Pubitemid 44043073)
37. Samuel VT, Beddow SA, Iwasaki T, Zhang XM, Chu X, Still CD, Gerhard GS, Shulman GI 2009 Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes. Proc Natl Acad Sci USA 106:12121-12126
38. Saito M, Bray GA 1983 Diurnal rhythm for corticosterone in obese (ob/ob) diabetes (db/db) and gold-thioglucose-induced obesity in mice. Endocrinology 113:2181-2185 (Pubitemid 14213586)
39. Oberhaensli RD, Rajagopalan B, Taylor DJ, Radda GK, Collins JE, Leonard JV, Schwarz H, Herschkowitz N 1987 Study of hereditary fructose intolerance by use of 31P magnetic resonance spectroscopy. Lancet 2:931-934 (Pubitemid 17150284)